Peptides-based vaccine against SARS-nCoV-2 antigenic fragmented synthetic epitopes recognized by T cell and β-cell initiation of specific antibodies to fight the infection

The World Health Organization has declared the rapidly spreading coronavirus to be a global pandemic. The FDA is yet to approve a vaccine for human novel coronavirus. Here, we developed a peptide-based vaccine and used high-throughput screening by molecular dynamics simulation to identify T-cell- an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abduljaleel, Zainularifeen, Al-Allaf, Faisal A., Aziz, Syed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856345/
https://www.ncbi.nlm.nih.gov/pubmed/33552630
http://dx.doi.org/10.1007/s42242-020-00114-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856345/
https://www.ncbi.nlm.nih.gov/pubmed/33552630
http://dx.doi.org/10.1007/s42242-020-00114-3

Ejemplares similares